Novo Nordisk's pricing tactics during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price gouging, stating the stark distinction among U.S. price ranges and those in Europe and copyright. California biotech behemoth Amgen ditched i